Sorption Therapy in Psoriatic Patients

Kolyadenko, V.G.; Amalyan, V A; Карпенко, В В; Korol, V N

doi:10.3109/10731198709118528

Biomaterials, Artificial Cells and Artificial Organs

1987

DOI: 10.3109/10731198709118528

|View full text |Cite

Sorption Therapy in Psoriatic Patients

V.G. Kolyadenko¹,

V A Amalyan²,

В В Карпенко³

et al.

Abstract: The results of psoriasis sorption therapy (hemosorption (HS), plasmosorption (PS), hemosorption with exchanged plasma transfusion) are presented in this work. Indices of immunity and clinical efficiency of sorption therapy in 89 examined patients are studied. It was determined that sorption therapy possessed therapeutic efficiency with clinical forms of dermatosis, it promotes the normalization of immunological status indices, blood aggregation condition and microcirculation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1992

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Dna-Coated Carbon Adsorbents Experimental Assessment and Results Op Severe Psoriasis Treatment

Snezhkova¹,

Kolyadenko²,

Vg³

et al. 1992

Biomaterials, Artificial Cells and Immobilization Biotechnology

View full text Add to dashboard Cite

Newly developed combined adsorbents, containing from 1 to 8 mg of thymic DNA per 1 g of the granulated or the fibrous carbonic matrix, demonstrated good biocompatibility and selectivity for DNA- and DNP-binding substances. In a group of 14 patients with severe psoriasis (uncontrol trial) a single hemoperfusion procedure through DNA-coated granulated synthetic carbons (perfusion volume was 2.5-3.1 L, sorbent quantity was 30 g) resulted in complete remission in 6 patients and in substantial improvement of clinical status in 6 other patients. A positive effect was observed in 4 patients during 7-11 months; in 8 patients it is being observed for more than 29-33 months. The double-blind tests in the group of patients subjected to hemoperfusion through the DNA-coated charcoal (27 people) and uncoated charcoal (9 people) showed the full-scale remission in 55.5% and 11.2% respectively. The authors believe that the DNA-coated activated carbons can be an effective therapeutic procedure for treatment of numerous immuno-dependent diseases and states associated with disorders in the kinetics of cell division.

show abstract

Dna-Coated Carbon Adsorbents Experimental Assessment and Results Op Severe Psoriasis Treatment

Snezhkova¹,

Kolyadenko²,

Vg³

et al. 1992

Biomaterials, Artificial Cells and Immobilization Biotechnology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Sorption Therapy in Psoriatic Patients

Cited by 1 publication

References 4 publications

Dna-Coated Carbon Adsorbents Experimental Assessment and Results Op Severe Psoriasis Treatment

Dna-Coated Carbon Adsorbents Experimental Assessment and Results Op Severe Psoriasis Treatment

Contact Info

Product

Resources

About